UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

British Migration: Privilege, Diversity and Vulnerability

1st, 2019

Volltextzugriff (PDF)

The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin

BMC musculoskeletal disorders, 2011-10, Vol.12 (1), p.247-247, Article 247

2011

Volltextzugriff (PDF)

Transcriptional responses in the adaptation to ischaemia-reperfusion injury: a study of the effect of ischaemic preconditioning in total knee arthroplasty patients

Journal of translational medicine, 2010-05, Vol.8 (1), p.46-46, Article 46

2010

Volltextzugriff (PDF)

Human Chondrocyte Viability After Treatment With Local Anesthetic and/or Magnesium: Results From an In Vitro Study

Arthroscopy, 2011-02, Vol.27 (2), p.213-217

2011

Volltextzugriff (PDF)

A cross-national study to objectively evaluate the quality of diverse simulation approaches for undergraduate nursing students

Nurse education in practice, 2018-01, Vol.28, p.248-256

2018

Volltextzugriff (PDF)

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria

Journal of allergy and clinical immunology, 2022-12, Vol.150 (6), p.1498-1506.e2

2022

Volltextzugriff (PDF)

Learning and teaching approaches promoting resilience in student nurses: An integrated review of the literature

Nurse education in practice, 2020-05, Vol.45, p.102748-102748, Article 102748

2020

Volltextzugriff (PDF)

Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1β

Journal of orthopaedics and traumatology, 2012-09, Vol.13 (3), p.119-123

2012

Volltextzugriff (PDF)

Kathleen's journey: improving mental health outcomes for women with bipolar affective disorder

British journal of midwifery, 2023-12, Vol.31 (12), p.695-700

2023

Volltextzugriff (PDF)

A novel in vitro model of ischaemic preconditioning: its effect on cell viability in human skeletal muscle and a possible explanation for the ‘second window of protection’

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2012-11, Vol.17 (6), p.802-807

2012

Volltextzugriff (PDF)

The creation of a confidence scale: the confidence in managing challenging situations scale

Journal of research in nursing, 2021-09, Vol.26 (6), p.483-496

2021

Volltextzugriff (PDF)

Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.479-486.e4

2024

Volltextzugriff (PDF)

53683 Remibrutinib provides sustained improvement in itch severity in patients with chronic spontaneous urticaria: Phase 2b open-label extension study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB80-AB80

2024

Volltextzugriff (PDF)

52636 Remibrutinib improves hive severity in patients with chronic spontaneous urticaria: 52-week results from a Phase 2b extension study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB297-AB297

2024

Volltextzugriff (PDF)

52859 Time to first relapse during treatment-free follow-up without remibrutinib in patients with chronic spontaneous urticaria (CSU): subgroup analysis by baseline disease status and CSU duration from a Phase 2b extension study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB340-AB340

2024

Volltextzugriff (PDF)

Remibrutinib Treatment Has No Impact on Blood Counts in Patients With Chronic Spontaneous Urticaria: Results From Phase 2b 52-week Extension Study Results

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB3

2024

Volltextzugriff (PDF)

Time to Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients With Chronic Spontaneous Urticaria: Subgroup Analysis By Baseline Immunoglobulin-E Levels and Chronic Urticaria Index Status From a Phase 2b Extension Study

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB266

2024

Volltextzugriff (PDF)

Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study

Journal of allergy and clinical immunology, 2023-02, Vol.151 (2), p.AB131-AB131

2023

Volltextzugriff (PDF)

52251 Remibrutinib reduces CSU symptoms and rescue medication use in patients with chronic spontaneous urticaria despite absence of background medication

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB81-AB81

2024

Volltextzugriff (PDF)

Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB6

2024

Volltextzugriff (PDF)

42939 Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB82-AB82

2023

Volltextzugriff (PDF)

Remibrutinib Treatment Improves Quality of Life in Patients with Chronic Spontaneous Urticaria

Journal of allergy and clinical immunology, 2022-02, Vol.149 (2), p.AB179-AB179

2022

Volltextzugriff (PDF)

Molecular Mechanism of Ischaemic Preconditioning of Skeletal Muscle In Vitro

Curēus (Palo Alto, CA), 2018-12

2018

Volltextzugriff (PDF)

A key transition for student nurses: The first placement experience

Nurse education today, 2012-10, Vol.32 (7), p.779-781

2012

Volltextzugriff (PDF)

Statins: A potential role in the management of osteoarthritis?

Joint, bone, spine : revue du rhumatisme, 2011-01, Vol.78 (1), p.31-34

2011

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(194)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

British Migration: Privilege, Diversity and Vulnerability

The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin

Transcriptional responses in the adaptation to ischaemia-reperfusion injury: a study of the effect of ischaemic preconditioning in total knee arthroplasty patients

Human Chondrocyte Viability After Treatment With Local Anesthetic and/or Magnesium: Results From an In Vitro Study

A cross-national study to objectively evaluate the quality of diverse simulation approaches for undergraduate nursing students

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria

Learning and teaching approaches promoting resilience in student nurses: An integrated review of the literature

Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1β

Kathleen's journey: improving mental health outcomes for women with bipolar affective disorder

A novel in vitro model of ischaemic preconditioning: its effect on cell viability in human skeletal muscle and a possible explanation for the ‘second window of protection’

The creation of a confidence scale: the confidence in managing challenging situations scale

Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks

53683 Remibrutinib provides sustained improvement in itch severity in patients with chronic spontaneous urticaria: Phase 2b open-label extension study

52636 Remibrutinib improves hive severity in patients with chronic spontaneous urticaria: 52-week results from a Phase 2b extension study

52859 Time to first relapse during treatment-free follow-up without remibrutinib in patients with chronic spontaneous urticaria (CSU): subgroup analysis by baseline disease status and CSU duration from a Phase 2b extension study

Remibrutinib Treatment Has No Impact on Blood Counts in Patients With Chronic Spontaneous Urticaria: Results From Phase 2b 52-week Extension Study Results

Time to Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients With Chronic Spontaneous Urticaria: Subgroup Analysis By Baseline Immunoglobulin-E Levels and Chronic Urticaria Index Status From a Phase 2b Extension Study

Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study

52251 Remibrutinib reduces CSU symptoms and rescue medication use in patients with chronic spontaneous urticaria despite absence of background medication

Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study

42939 Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results

Remibrutinib Treatment Improves Quality of Life in Patients with Chronic Spontaneous Urticaria

Molecular Mechanism of Ischaemic Preconditioning of Skeletal Muscle In Vitro

A key transition for student nurses: The first placement experience

Statins: A potential role in the management of osteoarthritis?

Suchergebnisse filtern